CPHI 2023
Interview: Going with the flow in drug substance manufacturing
Continuous flow manufacturing is taking off in the production of active pharmaceutical ingredients (APIs).
CPHI 2023
Continuous flow manufacturing is taking off in the production of active pharmaceutical ingredients (APIs).
In the midst of International Gaucher Disease Awareness Month, GlobalData has highlighted a 'critical' issue within the Gaucher disease landscape: the significant lack of neuronopathic therapies.
Paid for and in partnership with Lonza Small Molecules
Respiratory diseases require new treatments. Drug developers in the space can look to jet milling – a crucial process to create many dry powder inhaler products.